Acute effects of carprofen and meloxicam on canine gastrointestinal permeability and mucosal absorptive capacity

Journal of Veterinary Internal Medicine

Volumn 21, Issue 5, 2007, Pages 917-923

  Craven, Melanie ^a,e   Chandler, Marge L ^a   Steiner, Jörg M ^b   Farhadi, Ashkan ^c   Welsh, Elizabeth ^a   Pratschke, Kathryn ^a,f   Shaw, Darren J ^a,b,c,d,e,f   Williams, David A ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b TEXAS A AND M UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e Department of Obstetrics Gynecology   (United States)

^f Great Western Referrals   (United Kingdom)

Author keywords

Dogs; Intestinal function; Mucosal damage; Nonsteroidal; Sugar permeability

Indexed keywords

CARBAZOLE DERIVATIVE; CARBOHYDRATE; CARPROFEN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; DOG; DRUG EFFECT; FEMALE; INTESTINE ABSORPTION; INTESTINE MUCOSA; LONGITUDINAL STUDY; MALE; METABOLISM; NONPARAMETRIC TEST; PERMEABILITY; PROSPECTIVE STUDY; URINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBAZOLES; CARBOHYDRATES; DOGS; FEMALE; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LONGITUDINAL STUDIES; MALE; PERMEABILITY; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THIAZINES; THIAZOLES;

ANIMALIA; CANIS FAMILIARIS;

EID: 34848851942     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[917:AEOCAM]2.0.CO;2     Document Type: Article

References (53)

1. Meddings MD, Kirk D, Olson ME. Non-invasive detection of NSAID-induced gastropathy in dogs. Am J Vet Res 1995;56: 977-981.
2. Barrier CH, Hirschowitz BI. Current controversies in rheumatology: Controversies and management of non-steroidal anti-inflammatory drug induced side-effects on upper gastrointestinal tract. Arthritis Rheum 1989;32:926-929.
3. Adams HR. Veterinary Pharmacology and Therapeutics, 8th ed. Ames, IA: Iowa State University Press; 2001.
4. Lascelles BD, Blikslager AT, Fox SM, Reece D. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase inhibitor: 29 cases (2002-2003). J Am Vet Med Assoc 2005; 227:1112-1117.
5. Forsyth SF, Guilford WG, Haslett SJ, Godfrey J. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs. J Small Anim Pract 1998;39: 421-424.
6. Reimer ME, Johnston SA, Leib MS, et al. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs. J Vet Intern Med 1999;13:472-477.
7. Hinton LE, McLoughlin MA, Johnson SE, et al. Spontaneous gastroduodenal ulceration in 16 dogs and 7 cats (1982-1999). J Am Anim Hosp Assoc 2002;38:176-187.
8. Bjarnason I, Filvilly B, Smethurst P, et al. Importance of local versus systemic effects of non-steroidal anti-inflammatory drug in increasing small intestinal permeability in man. Gut 1986; 32:275-277.
9. Sigthorsson G, Tibble J, Hatllar J, et al. Intestinal permeability and inflammation in patients on NSAIDS. Gut 1998; 43:506-511.
10. Zhengwu S, Xiangdong W, Andersson R. Role of intestinal permeability in monitoring mucosal barrier function. Dig Surg 1998;15:386-397.
11. Henderson AK, Webster CRL. Disruption of the gastric mucosal barrier in dogs. Compend Cont Educ 2006;28:340-357.
12. Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to non-steroidal anti-inflammatory drugs. Gut 2001;49:650-655.
13. Vane JR, Bolting M. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47:S78-S87.
14. Gullikson GW, Sender M, Bass P. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J Pharmacol Exp Ther 1982;220:236-242.
15. Bjarnason I, Hallyar J. Early pathogenic effects in NSAID-induced gastrointestinal damage. Ital J Gastroenterol 1996;28:19-22.
16. Somasundaram S, Rafi S, Halyyar J, et al. Mitochondrial damage: A possible mechanism of the 'topical' phase of the NSAID-induced injury to rat intestine. Gut 1997;41:344-353.
17. Hata J, Kamada T, Manabe N, et al. Famotidine prevents canine gastric blood flow production by NSAIDs. Aliment Pharmacol Ther 2005;21:55-59.
18. Taha AS, Nakhasbendi J, Lee FD, et al. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving nonsteroidal anti-inflammatory drugs: Comparison and correlation with peptic ulceration. J Clin Pathol 1992;45:135-139.
19. McCarthy CJ, McDermott M, Hourihone D, et al. Chemical gastritis induced by naproxen in the absence of Helicobacter to pylori infection. J Clin Pathol 1995;48:61-63.
20. Thiefin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 2005;25:286-294.
21. Schneider AR, Benz C, Riemann JF. Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel. Endoscopy 1999;31:761-767.
22. Sessions JK, Reynolds LR, Budsberg SC. In vivo effects of carprofen, deracoxib and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis. Am J Vet Res 2004;66:812-817.
23. Streppa HK, Jones CJ, Budsberg SC. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Am J Vet Res 2002;63:91-94. 24. Ricketts AP, Lundy KM, Seibel SB. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am J Vet Res 1998;59: 1441-1446.
24. Bergh MS, Budsberg SC. The coxib NSAIDS: Potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med 2005;19:633-643.
25. Jones CJ, Streppa HK, Harmon BG, Budsberg SC. In vivo effects of meloxicam and aspirin on blood, gastric mucosal and synovial fluid prostanoid synthesis in dogs. Am J Vet Res 2002;63: 1527-1531.
26. Stanton ME, Bright RM. Gastroduodenal ulceration in dogs: Retrospective study of 43 cases and literature review. J Vet Intern Med 1989;3:238-244.
27. Meddings JB, Wallace JL, Sutherland LR. Sucrose permeability: A novel means of detecting gastroduodenal damage noninvasively. Am J Ther 1995;11:843-849.
28. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998;114:83-92.
29. Davies NM. Review article: Non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther 1998;12:303-320.
30. Kou YJ, Shanbour LL. Mechanism of action of aspirin on canine gastric mucosa. Am J Physiol 1976;23:762-767.
31. Meyer RA, McGinley D, Posalaky Z. Effects of aspirin on tight junction structure of the canine gastric mucosa. Gastroenterology 1986;91:351-359.
32. Steiner JM, Williams DA, Moeller EM. Development and validation of a method for simultaneous separation and quantification of five different sugars in canine urine. Can J Vet Res 2000;64:164-170.
33. Steiner JM, Williams DA, Moeller EM. Kinetics of urinary recovery of five sugars after orogastric administration in healthy dogs. Am J Vet Res 2002;63:845-848.
34. Quigg J, Brydon G, Ferguson A, et al. Evaluation of canine small intestinal permeability using the lactulose/rhamnose urinary excretion test. Res Vet Sci 1993;55:326-332.
35. Wood SG, John BA, Hawkins DR. The pharmacokinetics and metabolism of sucralose in the dog. Food Chem Toxicol 2000; 38:S99-S106.
36. Rutgers HC, Batt RM, Proud FJ, et al. Intestinal permeability and function in dogs with small intestinal bacterial overgrowth. J Small Anim Pract 1996;37:428-434.
37. Anderson AD, Jain PK, Fleming S, et al. Evaluation of a triple sugar test of colonic permeability in humans. Acta Physiol Scand 2004;182:171-177.
38. Farhadi A, Keshavarzian A, Holmes EW, et al. Gas Chromatographie method for detection of urinary sucralose: Application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 2003;25:145-154.
39. Raekallio MR, Hielm-Bjorkman AK, Kejonen J, et al. Evaluation of adverse effects of long-term orally administered carprofen in dogs. J Am Vet Med Assoc 2006;228:876-880.
40. Boston SE, Moens NM, Kruth SA, Southern EP. Endoscopic evaluation of the gastroduodenal mucosa to determine the safety of short-term concurrent administration of meloxicam and dexamethasone in healthy dogs. Am J Vet Res 2003;64:1369-1375.
41. Yousfi MM, De Petris G, Leighton JA, et al. Diaphragm disease after use of nonsteroidal anti-inflammatory agents: First report of diagnosis with capsule endoscopy. J Clin Gastroenterol 2004;38:686-691.
42. Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133-141.
43. Meling TR, Aabakken L, Roseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31:339-344.
44. Tibble JA, Sigthorsson G, Foster R, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-366.
45. Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996; 35:4-12.
46. Smale S, Bjarnason I. Determining small bowel integrity following drug treatment. Br J Clin Pharmacol 2003;56:284-291.
47. Langenbach R, Morham SG, Tiano HF, et al. Disruption of the mouse cyclooxygenase 1 gene: Characteristics of the mutant and areas of future study. Adv Exp Med Biol 1997;407:87-92.
48. Curry SL, Cogar SM, Cook JL. Nonsteroidal antiinflammatory drugs: A review. J Am Anim Hosp Assoc 2005;41:298-309.
49. Moreau M, Daminet S, Martel-Pelletier J, et al. Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs. J Vet Pharmacol Ther 2005; 28:81-86.
50. Wallace MS, Zawie PA, Garpy MS. Gastric ulceration in the dog secondary to non-steroidal anti-inflammatory drugs. J Am Anim Hosp Assoc 1995;26:467-472.
51. Bergh MS, Budsberg SC. The coxib NSAIDs: Potential clinical and pharmacologic importance in veterinary medicine. J Vet Intern Med 2005;19:633-643.
52. Jones RD, Baynes RE, Nimitz CT. Non-steroidal antiinflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990). J Am Vet Med Assoc 1992;201:475-477.
53. Reed S. Non-steroidal anti-inflammatory drug-induced duodenal ulceration and perforation in a mature Rottweiler. Can Vet J 2002;43:971-972.